DT-Web

DB00326 - Calcium Gluceptate


Identification
Name Calcium Gluceptate
Accession Number DB00326 (APRD00841)
Type small molecule
Description Calcium supplements such as calcium gluceptate are taken by individuals who are unable to get enough calcium in their regular diet or who have a need for more calcium. They are used to prevent or treat several conditions that may cause hypocalcemia (not enough calcium in the blood). The body needs calcium to make strong bones. Calcium is also needed for the heart, muscles, and nervous system to work properly.
Structure
MOL SDF PDB SMILES InChI
Categories (*)
Molecular Weight 490.425
Groups approved
Monoisotopic Weight 490.084675939
Pharmacology
Indication For treatment of mild hypocalcemia due to neonatal tetany, tetany due to parathyroid deficiency or vitamin D deficiency, and alkalosis, as prophylaxis of hypocalcemia during exchange transfusions, in the treatment of intestinal malabsorption, and to replenish electrolytes.
Mechanism of action Calcium gluceptate replenishes the deminished levels of calcium in the body, returning them to normal levels.
Absorption Rapidly absorbed following oral administration.
Protein binding Not Available
Biotransformation Not Available
Route of elimination Not Available
Toxicity Symptoms of overdose include confusion, drowsiness (severe), high blood pressure, increased sensitivity of eyes or skin to light, irregular, fast, or slow heartbeat, and unusually large amount of urine or increased frequency of urination.
Affected organisms
  • Humans and other mammals
Interactions
Drug Interactions
Drug Mechanism of interaction
Trovafloxacin Calcium may decrease the absorption of orally administered Trovafloxacin. Administer Trovafloxacin 2 hours before or 6 hours after a dose of the calcium containing agent to minimize the interaction.
Food Interactions Not Available

Predictions


Id Partner name Gene Name Score
↑